Thomas Barnes from Intellia Therapeutics gave a talk to Corn Lab

The management and research teams from Intellia Therapeutics came to visit UC Berkeley today. Thomas Barnes, Ph.D., the Senior Vice President of Innovative Sciences & eXtellia, and his teams shared their scientific expertise in CRISPR/Cas9 technology and clinical development experience to the members in Corn lab.

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

September 8, 2023

THE EXPLAINER VIDEO FEATURING OUR HBD PROMOTER RESEARCH IS NOW LIVE!

Check out our new animated video highlighting Mandy’s research on HBD promoter engineering!

 

To learn more, please refer to this article on Elife...

September 7, 2023

Welcome to Iryna!

Iryna Vykhlyantseva completed her master’s degree in Biotechnology in late 2022. She joined the Corn Lab’s supporting the GEML team as a research...

September 7, 2023

Welcome to Xin!

Xin Luo received her Bachelor’s degree from University of Melbourne in 2021. She is currently enrolled in the Biochemistry Master’s program at ETH Zürich....

News Archive

Tweets